Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Trading Down 1.1% – What’s Next?

Shares of Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) traded down 1.1% on Monday . The stock traded as low as $28.75 and last traded at $28.77. 7,997 shares were traded during mid-day trading, a decline of 73% from the average session volume of 29,908 shares. The stock had previously closed at $29.09.

Invesco Nasdaq Biotechnology ETF Stock Down 1.8%

The company has a market cap of $64.91 million, a price-to-earnings ratio of 17.03 and a beta of 0.62. The firm has a 50 day moving average price of $29.40 and a two-hundred day moving average price of $29.09.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 27th. Stockholders of record on Monday, March 23rd were paid a $0.0361 dividend. The ex-dividend date of this dividend was Monday, March 23rd. This represents a $0.14 annualized dividend and a dividend yield of 0.5%.

Institutional Investors Weigh In On Invesco Nasdaq Biotechnology ETF

Several large investors have recently added to or reduced their stakes in IBBQ. Raymond James Financial Inc. acquired a new stake in Invesco Nasdaq Biotechnology ETF during the second quarter worth approximately $149,000. IHT Wealth Management LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF during the second quarter worth approximately $211,000. Osaic Holdings Inc. grew its stake in Invesco Nasdaq Biotechnology ETF by 28.4% during the second quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after purchasing an additional 1,052 shares during the period. GeoWealth Management LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF during the third quarter worth approximately $451,000. Finally, Advisory Services Network LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF during the third quarter worth approximately $52,000.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.